Rac1 regulates platelet shedding of CD40L in abdominal sepsis

Laboratory Investigation

Volumn 94, Issue 9, 2014, Pages 1054-1063

  Hwaiz, Rundk ^a   Rahman, Milladur ^a   Zhang, Enming ^b   Thorlacius, Henrik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMEN; ANIMALS; BLOOD PLATELETS; CD40 LIGAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; MALE; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; NEUTROPHILS; RAC1 GTP-BINDING PROTEIN; SEPSIS;

EID: 84906824559     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.92     Document Type: Article

References (51)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891.
2. Heyland DK, Hopman W, Coo H, et al. Long-term health-related qualityof life in survivors of sepsis. Short Form 36: A valid and reliablemeasure of health-related quality of life. Crit Care Med 2000;28:3599-3605.
3. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis inthe United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
4. Asaduzzaman M, Zhang S, Lavasani S, et al. LFA-1 and Mac-1 mediatepulmonary recruitment of neutrophils and tissue damage in abdominalsepsis. Shock 2008;30:254-259.
5. Bacon KB, Oppenheim JJ. Chemokines in disease models andpathogenesis. Cytok Growth Factor Rev 1998;9:167-173.
6. Hasan Z, Palani K, Rahman M, et al. Targeting CD44 expressed onneutrophils inhibits lung damage in abdominal sepsis. Shock 2011;35:567-572.
7. Zhang S, Song L, Wang Y, et al. Targeting CD162 protects againststreptococcal M1 protein-evoked neutrophil recruitment and lunginjury. Am J Physiol 2013;305:L756-L763.
8. Rahman M, Zhang S, Chew M, et al. Platelet-derived CD40L (CD154)mediates neutrophil upregulation of Mac-1 and recruitment in septiclung injury. Ann Surg 2009;250:783-790.
9. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet- neutrophilinteractions: Linking hemostasis and inflammation. Blood Rev 2007;21:99-111.
10. Rahman M, Zhang S, Chew M, et al. Platelet shedding of CD40Lis regulated by matrix metalloproteinase-9 in abdominal sepsis.J Thromb Haemostas 2013;11:1385-1398.
11. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance.J Endotox Res 2004;10:71-84.
12. Kim JM, Oh YK, Lee JH, et al. Induction of proinflammatory mediatorsrequires activation of the TRAF, NIK, IKK and NF-kappaB signaltransduction pathway in astrocytes infected with Escherichia coli.Clin Exp Immunol 2005;140:450-460.
13. Itoh K, Yoshioka K, Akedo H, et al. An essential part for Rho-associatedkinase in the transcellular invasion of tumor cells. Nat Med 1999;5:221-225.
14. Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascularphysiology and pathophysiology. Circ Res 2006;98:322-334.
15. Narumiya S. The small GTPase Rho: Cellular functions and signaltransduction. J Biochem 1996;120:215-228.
16. Slotta JE, Braun OO, Menger MD, et al. Fasudil, a Rho-kinase inhibitor,inhibits leukocyte adhesion in inflamed large blood vessels in vivo.Inflam Res 2006;55:364-367.
17. Hwaiz R, Hasan Z, Rahman M, et al. Rac1 signaling regulates sepsisinducedpathologic inflammation in the lung via attenuation ofMac-1 expression and CXC chemokine formation. J Surg Res 2013;183:798-807.
18. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature2002;420:629-635.
19. Akbar H, Kim J, Funk K, et al. Genetic and pharmacologic evidencethat Rac1 GTPase is involved in regulation of platelet secretion andaggregation. J Thromb Haemostas 2007;5:1747-1755.
20. Flevaris P, Li Z, Zhang G, et al. Two distinct roles of mitogen-activatedprotein kinases in platelets and a novel Rac1-MAPK- dependentintegrin outside-in retractile signaling pathway. Blood 2009;113:893-901.
21. Guidetti GF, Bernardi B, Consonni A, et al. Integrin alpha2beta1induces phosphorylation-dependent and phosphorylation-independentactivation of phospholipase Cgamma2 in platelets: Role of Srckinase and Rac GTPase. J Thromb Haemostas 2009;7:1200-1206.
22. McCarty OJ, Larson MK, Auger JM, et al. Rac1 is essential for plateletlamellipodia formation and aggregate stability under flow. J BiolChem 2005;280:39474-39484.
23. Pandey D, Goyal P, Dwivedi S, et al. Unraveling a novel Rac1-mediatedsignaling pathway that regulates cofilin dephosphorylation and secretionin thrombin-stimulated platelets. Blood 2009;114:415-424.
24. Pleines I, Elvers M, Strehl A, et al. Rac1 is essential for phospholipaseC-gamma2 activation in platelets. Pflug Archiv 2009;457:1173-1185.
25. Binker MG, Binker-Cosen AA, Gaisano HY, et al. Inhibition of Rac1decreases the severity of pancreatitis and pancreatitis-associated lunginjury in mice. Exp Physiol 2008;93:1091-1103.
26. Harada N, Iimuro Y, Nitta T, et al. Inactivation of the small GTPase Rac1protects the liver from ischemia/reperfusion injury in the rat. Surgery2003;134:480-491.
27. Yao HY, Chen L, Xu C, et al. Inhibition of Rac activity alleviateslipopolysaccharide-induced acute pulmonary injury in mice. Bio chim Biophys Acta 2011;1810:666-674.
28. Rittirsch D, Huber-Lang MS, Flierl MA, et al. Immunodesign of experimentalsepsis by cecal ligation and puncture. Nat Protocol 2009;4:31-36.
29. Pugin J, Widmer MC, Kossodo S, et al. Human neutrophils secretegelatinase B in vitro and in vivo in response to endotoxin andproinflammatory mediators. Am J Resp Cell Mol Biol 1999;20:458-464.
30. Asaduzzaman M, Rahman M, Jeppsson B, et al. P-selectin glycoproteinligand-1 regulates pulmonary recruitment of neutrophils in a plateletindependentmanner in abdominal sepsis. Br J Pharmacol 2009;156:307-315.
31. Flad HD, Brandt E. Platelet-derived chemokines: Pathophysiology andtherapeutic aspects. Cell Mol Life Sci 2010;67:2363-2386.
32. Yan Z, Zhang J, Holt JC, et al. Structural requirements of plateletchemokines for neutrophil activation. Blood 1994;84:2329-2339.
33. Chew M, Rahman M, Ihrman L, et al. Soluble CD40L (CD154) isincreased in patients with shock. Inflam Res 2010;59:979-982.
34. Inwald DP, Faust SN, Lister P, et al. Platelet and soluble CD40L inmeningococcal sepsis. Intens Care Med 2006;32:1432-1437.
35. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity.Matrix Biol 2007;26:587-596.
36. Stamenkovic I. Extracellular matrix remodelling: The role of matrixmetalloproteinases. J Pathol 2003;200:448-464.
37. Paemen L, Jansen PM, Proost P, et al. Induction of gelatinase B andMCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine1997;9:412-415.
38. Teng L, Yu M, Li JM, et al. Matrix metalloproteinase-9 as new biomarkersof severity in multiple organ dysfunction syndrome caused bytrauma and infection. Mol Cell Biochem 2012;360:271-277.
39. Torrence AE, Brabb T, Viney JL, et al. Serum biomarkers in a mousemodel of bacterial-induced inflammatory bowel disease. Inflam Bowel Dis 2008;14:480-490.
40. Nakamura T, Ebihara I, Shimada N, et al. Modulation of plasmametalloproteinase-9 concentrations and peripheral blood monocytemRNA levels in patients with septic shock: Effect of fiber-immobilizedpolymyxin B treatment. Am J Med Sci 1998;316:355-360.
41. Choi WS, Jeon OH, Kim DS. CD40 ligand shedding is regulated byinteraction between matrix metalloproteinase-2 and platelet integrinalpha(IIb)beta(3). J Thromb Haemostas 2010;8:1364-1371.
42. Reinboldt S, Wenzel F, Rauch BH, et al. Preliminary evidence for amatrix metalloproteinase-2 (MMP-2)-dependent shedding of solubleCD40 ligand (sCD40L) from activated platelets. Platelets 2009;20:441-444.
43. Cecchetti L, Tolley ND, Michetti N, et al. Megakaryocytes differentiallysort mRNAs for matrix metalloproteinases and their inhibitors intoplatelets: A mechanism for regulating synthetic events. Blood 2011;118:1903-1911.
44. Galt SW, Lindemann S, Medd D, et al. Differential regulation of matrixmetalloproteinase-9 by monocytes adherent to collagen and platelets.Circ Res 2001;89:509-516.
45. Fernandez-Patron C, Martinez-Cuesta MA, Salas E, et al. Differentialregulation of platelet aggregation by matrix metalloproteinases- 9and-2. Thromb Haemostas 1999;82:1730-1735.
46. Mannello F. Serum or plasma samples? The 'Cinderella' role ofblood collection procedures: Preanalytical methodological issuesinfluence the release and activity of circulating matrix metallo-proteinases and their tissue inhibitors, hampering diagnostic truenessand leading to misinterpretation. Arterioscler Thromb Vasc Biol 2008;28:611-614.
47. Menchen L, Marin-Jimenez I, Arias-Salgado EG, et al. Matrix metalloproteinase9 is involved in Crohn's disease-associated platelethyperactivation through the release of soluble CD40 ligand. Gut2009;58:920-928.
48. Lindsey M, Wedin K, Brown MD, et al. Matrix-dependent mechanismof neutrophil-mediated release and activation of matrix metalloproteinase9 in myocardial ischemia/reperfusion. Circulation 2001;103:2181-2187.
49. Katsumi A, Milanini J, Kiosses WB, et al. Effects of cell tension on thesmall GTPase Rac. J Cell Biol 2002;158:153-164.
50. Razzouk S, Lieberherr M, Cournot G. Rac-GTPase, osteoclast cytoskeletonand bone resorption. Eur J Cell biol 1999;78:249-255.
51. Woo CH, Jeong DT, Yoon SB, et al. Eotaxin induces migration of RBL-2H3 mast cells via a Rac-ERK-dependent pathway. Bio chem Biophys Res Commun 2002;298:392-397.